drug discovery

News

Sanofi, CytoReason expand AI deal into IBD

Tech company CytoReason has announced it has signed a multi-year, multimillion dollar deal with Sanofi to deliver artificial intelligence (AI) for drug discovery and development in the fiel

News

Bayer taps Google's quantum power for drug discovery

Bayer has signed an agreement with Google aimed at using high-level processing power to handle quantum chemistry calculations used to predict the chemical and physical properties of drug mo

Digital

AI and the Big Data paradigm – big ambitions in novel drug d...

Over the past few decades, data generation has veritably exploded.

News

BioNTech buys UK-based AI startup InstaDeep in £562m deal

mRNA specialist BioNTech has driven its partnership with UK artificial intelligence InstaDeep into top gear, agreeing to buy the company outright in a cash and equity deal that values it at

News

Sanofi signs $1.2bn research alliance with AI specialist Ins...

Sanofi has tapped into the artificial intelligence expertise of Chinese biotech Insilico Medicine with a six-compound drug discovery collaboration that could be worth up to $1.2 billion.

News